The clinical spectrum associated with myelin oligodendrocyte glycoprotein antibodies (anti-MOG-Ab) in Thai patients
暂无分享,去创建一个
[1] T. Nakazawa,et al. MRI and retinal abnormalities in isolated optic neuritis with myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies: a comparative study , 2015, Journal of Neurology, Neurosurgery & Psychiatry.
[2] K. Fujihara,et al. Influenza-associated MOG antibody-positive longitudinally extensive transverse myelitis: a case report , 2014, BMC Neurology.
[3] T. Kezuka,et al. Distinction between MOG antibody–positive and AQP4 antibody–positive NMO spectrum disorders , 2014, Neurology.
[4] Masami Tanaka,et al. Anti-MOG antibodies in adult patients with demyelinating disorders of the central nervous system , 2014, Journal of Neuroimmunology.
[5] Jacqueline A Palace,et al. Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study. , 2014, JAMA neurology.
[6] K. Rostásy,et al. The spectrum of MOG autoantibody-associated demyelinating diseases , 2013, Nature Reviews Neurology.
[7] Jacqueline A Palace,et al. Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype , 2012, Neurology.
[8] Y. Itoyama,et al. Neuromyelitis optica should be classified as an astrocytopathic disease rather than a demyelinating disease , 2012 .
[9] B. Weinshenker,et al. The spectrum of neuromyelitis optica , 2007, The Lancet Neurology.
[10] Ichiro Nakashima,et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis , 2004, The Lancet.